
Amar Ambani of IIFL has evaluated the Q3FY16 performance of several stocks and given buy/ sell recommendations with price targets
Top brass managements usually keep a stiff upper lip when confronted with negative reports of analysts about their companies. However, Kiran Mazumdar Shaw of Biocon has adopted a combative stance and is proactively trashing the negative reports as being “illogical” and based on “poor understanding” while lauding the ones that are favourable to the Company
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Rakesh Jhunjhunwala
Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala
Recent Comments